369 related articles for article (PubMed ID: 24882401)
1. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.
Kuboyama T; Tohda C; Komatsu K
Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401
[TBL] [Abstract][Full Text] [Related]
2. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
3. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative diseases and Withania somnifera (L.): An update.
Dar NJ; MuzamilAhmad
J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781
[TBL] [Abstract][Full Text] [Related]
5. [Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unraveling pathophysiological mechanisms].
Tohda C
Yakugaku Zasshi; 2008 Aug; 128(8):1159-67. PubMed ID: 18670181
[TBL] [Abstract][Full Text] [Related]
6. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults.
Tiwari S; Gupta SK; Pathak AK
J Ethnopharmacol; 2021 May; 272():113929. PubMed ID: 33600918
[TBL] [Abstract][Full Text] [Related]
8. Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila.
Murthy MN; Shyamala BV
J Ethnopharmacol; 2024 Jan; 318(Pt A):116897. PubMed ID: 37442493
[TBL] [Abstract][Full Text] [Related]
9. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
10. Ashwagandha in brain disorders: A review of recent developments.
Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S
J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions.
Choudhary D; Bhattacharyya S; Bose S
J Diet Suppl; 2017 Nov; 14(6):599-612. PubMed ID: 28471731
[TBL] [Abstract][Full Text] [Related]
12. Keeping abreast about ashwagandha in breast cancer.
Vashi R; Patel BM; Goyal RK
J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
[TBL] [Abstract][Full Text] [Related]
13. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing.
Joshi VK; Joshi A
J Ethnopharmacol; 2021 Aug; 276():114101. PubMed ID: 33831467
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury.
Saykally JN; Hatic H; Keeley KL; Jain SC; Ravindranath V; Citron BA
Cell Transplant; 2017 Jul; 26(7):1193-1201. PubMed ID: 28933215
[TBL] [Abstract][Full Text] [Related]
15. Safety and clinical effectiveness of Withania Somnifera (Linn.) Dunal root in human ailments.
Tandon N; Yadav SS
J Ethnopharmacol; 2020 Jun; 255():112768. PubMed ID: 32201301
[TBL] [Abstract][Full Text] [Related]
16. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A
Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents.
Yenisetti SC; Manjunath MJ; Muralidhara C
Recent Pat CNS Drug Discov; 2016; 10(2):204-215. PubMed ID: 27316579
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction.
Ng QX; Loke W; Foo NX; Tan WJ; Chan HW; Lim DY; Yeo WS
Phytother Res; 2020 Mar; 34(3):583-590. PubMed ID: 31742775
[TBL] [Abstract][Full Text] [Related]
19. Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.
Lim DW; Kim JG; Lim EY; Kim YT
Inflammopharmacology; 2018 Feb; 26(1):207-215. PubMed ID: 28849547
[TBL] [Abstract][Full Text] [Related]
20. Neuro-protective potential of a vesicular system of a standardized extract of a new chemotype of Withania somnifera Dunal (NMITLI118RT+) against cerebral stroke in rats
Ahmad H; Khandelwal K; Samuel SS; Tripathi S; Mitra K; Sangwan RS; Shukla R; Dwivedi AK
Drug Deliv; 2016 Sep; 23(7):2630-2641. PubMed ID: 26017242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
